51 related articles for article (PubMed ID: 32289399)
1. Mohs micrographic surgery challenges and new technologies to optimize care of cutaneous malignancies of the ear.
Colao B; Khachemoune A
Arch Dermatol Res; 2024 Jun; 316(6):320. PubMed ID: 38822894
[TBL] [Abstract][Full Text] [Related]
2. Potential of dermoscopy with standard excision as an alternative to Mohs micrographic surgery for basal cell carcinoma.
Mehta H; Vinay K; Dogra S
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):124-125. PubMed ID: 37609725
[No Abstract] [Full Text] [Related]
3. Epidemiology of facial skin cancers managed in a French ambulatory surgical center.
Mathieu O; Chaine A; Benassarou M; Combes F; Debelmas A; Lanciaux S; Bertolus C; Bouaoud J
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3):101726. PubMed ID: 38056693
[TBL] [Abstract][Full Text] [Related]
4. Environmental and economic considerations for diagnostic biopsies in basal cell carcinomas. Comment on 'Biopsy type does not affect the number of stages during Mohs micrographic surgery: a retrospective study'.
Afzal UM; Ali FR
Clin Exp Dermatol; 2023 Jul; 48(7):809-810. PubMed ID: 37119273
[No Abstract] [Full Text] [Related]
5. Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management.
Verykiou S; Oliphant TJ; Rahim R; Husain A; Lawrence CM; Langtry JA
Br J Dermatol; 2016 Mar; 174(3):649-51. PubMed ID: 26399472
[No Abstract] [Full Text] [Related]
6. Basal cell carcinosarcoma: a systematic review and reappraisal of its challenges and the role of Mohs surgery.
Born LJ; Khachemoune A
Arch Dermatol Res; 2023 Oct; 315(8):2195-2205. PubMed ID: 36790451
[TBL] [Abstract][Full Text] [Related]
7. Concordance of basal cell carcinoma subtyping at biopsy vs. excision, and the implications for clinical approach: a multicenter cohort study.
Alam M; Whittington A; Nadir U; Yi MD; Dave L; Ikmal Hisham F; Cahn BA; Minkis K; Schlessinger DI; Schaeffer M; Reynolds KA; Veledar E; Poon E; Yoo SS; Krol C; Tung R; Bolotin D
Arch Dermatol Res; 2023 Dec; 316(1):23. PubMed ID: 38059991
[No Abstract] [Full Text] [Related]
8. Benefit of skin surgical revision in high-risk basal cell carcinoma according to histopathological margins.
Reynaud B; Jacquemus J; Chabaud S; Ouldbey Y; Darnis S; Amini-Adle M
Br J Dermatol; 2023 Dec; 190(1):129-131. PubMed ID: 37766499
[No Abstract] [Full Text] [Related]
9. Basal cell carcinoma resolution following diagnostic periocular punch biopsy: is surveillance an option?
Samia-Aly E; Ahluwalia H
Int J Dermatol; 2024 Jun; 63(6):827. PubMed ID: 38605471
[No Abstract] [Full Text] [Related]
10. Beyond clear margins: What matters to patients with basal cell carcinoma?
Vijayan R; Phillips KHT
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():103-104. PubMed ID: 38412599
[No Abstract] [Full Text] [Related]
11. Pigmented basal cell carcinoma of the nipple.
Elias ML; Gottesman SP; Sharon VR
Int J Dermatol; 2023 Oct; 62(10):e567-e569. PubMed ID: 37092594
[No Abstract] [Full Text] [Related]
12. How We Do It: Ad Hoc Immunohistochemistry for Challenging Mohs Cases.
Merkel EA; Alomari AK; Somani AK
Dermatol Surg; 2024 Jan; 50(1):100-101. PubMed ID: 37788240
[No Abstract] [Full Text] [Related]
13. Retrospective Review of Basal Cell Carcinomas in Self-Identified Minority Patients at a Single Academic Institution.
Greif C; Anderson M; Abbas L; Rose EK; Srivastava D; Nijhawan RI
Dermatol Surg; 2023 Dec; 49(12):1057-1060. PubMed ID: 37962977
[No Abstract] [Full Text] [Related]
14. Validation of a representative cohort of Mohs surgeons for survey studies.
Ahmed A; Haq M; Ma M; Koza E; Shi V; Andoni V; Pearlman R; Schlessinger DI; Cahn BA; Alam M
Arch Dermatol Res; 2024 May; 316(5):171. PubMed ID: 38744757
[No Abstract] [Full Text] [Related]
15. Identification of skin tumors margins using Wood's light: "The umbrella effect".
Gil-Pallares P; Muelas-Rives I; Navarro-Bielsa A; Gilaberte Y; Suárez-Peñaranda JM
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104089. PubMed ID: 38636885
[No Abstract] [Full Text] [Related]
16. Validating a novel natural language processing pathway for automated quality assurance in surgical oncology: incomplete excision rates of 34 955 basal cell carcinomas.
Ali SR; Dobbs TD; Jovic M; Strafford H; Fonferko-Shadrach B; Lacey AS; Williams N; Pickrell WO; Hutchings HA; Whitaker IS
Br J Surg; 2023 Aug; 110(9):1072-1075. PubMed ID: 36935397
[No Abstract] [Full Text] [Related]
17. Basal cell carcinomas of the ear are more aggressive and have higher discordance rates between biopsy and Mohs histopathology.
Navrazhina K; Parra CE; Cressey BD; Xanthos C; Christos PJ; Minkis K
J Am Acad Dermatol; 2020 Dec; 83(6):1805-1807. PubMed ID: 32289399
[No Abstract] [Full Text] [Related]
18. Primary Cutaneous Extraskeletal Osteosarcoma of the Temple Treated by Mohs Micrographic Surgery.
Govas P; Barnes L; Carroll BT
Dermatol Surg; 2020 Oct; 46(10):1340-1342. PubMed ID: 31397773
[No Abstract] [Full Text] [Related]
19. Surgical Outcomes and Risk Factors for Apical Triangle Basal Cell Carcinomas: A Single Institution Analysis.
Zhang J; Erickson S; Semenov YR; Council ML
Dermatol Surg; 2021 Aug; 47(8):1125-1127. PubMed ID: 33867464
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
